Bone-marrow-derived mesenchymal stromal cells (MSCs) are currently considered among the best candidates for cell-based therapy in regenerative medicine due to their ability to secrete paracrine factors with multiple effects on the injured tissue, including modulation of inflammation and immune reaction, ECM remodeling, angiogenesis and protection from apoptosis [1]. Moreover, MSCs have been proved, in some tissues, to affect the fate of resident progenitor cells by positively influencing the endogenous mechanisms of tissue repair/regeneration [2,3]. We have recently demonstrated that MSCs are able to produce and secrete sphingosine 1-phosphate (S1P), a bioactive lipid exerting a broad range of biological responses in many cell types [4]. On these bases, the aim of this study was to evaluate whether S1P could exert an autocrine effect on MSCs, influencing expression and release of enzymes involved in the ECM remodeling, namely matrix metalloproteinases (MMPs), such as MMP2 and its activator MT1-MMP/MMP14. By multiple approaches (confocal immunofluorescence, western blotting, zymography and gelatinase assays) we first found that MSCs express and release active MMP2 and MT1-MMP/MMP14. These cellular events appear to be mediated by S1P1, a specific G-coupled receptor subtype of the bioactive lipid, abundantly expressed in MSCs. In fact, when MSCs were cultured in the presence of a specific S1P1 antagonist (W146) they exhibited a down-regulation of MMP2 and MT1-MMP/MMP14; of note the addition of a receptor agonist (SEW 2871) was not able to up-regulate MMPs thus suggesting that S1P1 signalling plays a trophic role in MSCs. In parallel experiments, the expression of MMP2 and MT1-MMP/MMP14 was evaluated in MSCs cultured in low oxygen conditions (2%) in order to mimic the hypoxic microenvironment occurring in a damaged/regenerating tissue. These preliminary data contribute to add new insights into the functional mechanisms by which MSCs exert beneficial effects on tissue repair/regeneration.
Regulation of MMP2 and MT1-MMP/MMP14 expression in mesenchymal stromal cells: a role for the bioactive lipid sphingosine 1-phosphate / Chiara, Sassoli; Alessia, Tani; Flaminia, Chellini; Federica, Pierucci; Elena, Bruzzone; Larissa, Vallone; Daniele, Nosi; Francesca, Matteini; Elisabetta, Meacci; Sandra, Zecchi. - In: ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY. - ISSN 1122-6714. - STAMPA. - 120:(2015), pp. 133-133.
Regulation of MMP2 and MT1-MMP/MMP14 expression in mesenchymal stromal cells: a role for the bioactive lipid sphingosine 1-phosphate
SASSOLI, CHIARA;TANI, ALESSIA;CHELLINI, FLAMINIA;PIERUCCI, FEDERICA;VALLONE, LARISSA;NOSI, DANIELE;MEACCI, ELISABETTA;ZECCHI, SANDRA
2015
Abstract
Bone-marrow-derived mesenchymal stromal cells (MSCs) are currently considered among the best candidates for cell-based therapy in regenerative medicine due to their ability to secrete paracrine factors with multiple effects on the injured tissue, including modulation of inflammation and immune reaction, ECM remodeling, angiogenesis and protection from apoptosis [1]. Moreover, MSCs have been proved, in some tissues, to affect the fate of resident progenitor cells by positively influencing the endogenous mechanisms of tissue repair/regeneration [2,3]. We have recently demonstrated that MSCs are able to produce and secrete sphingosine 1-phosphate (S1P), a bioactive lipid exerting a broad range of biological responses in many cell types [4]. On these bases, the aim of this study was to evaluate whether S1P could exert an autocrine effect on MSCs, influencing expression and release of enzymes involved in the ECM remodeling, namely matrix metalloproteinases (MMPs), such as MMP2 and its activator MT1-MMP/MMP14. By multiple approaches (confocal immunofluorescence, western blotting, zymography and gelatinase assays) we first found that MSCs express and release active MMP2 and MT1-MMP/MMP14. These cellular events appear to be mediated by S1P1, a specific G-coupled receptor subtype of the bioactive lipid, abundantly expressed in MSCs. In fact, when MSCs were cultured in the presence of a specific S1P1 antagonist (W146) they exhibited a down-regulation of MMP2 and MT1-MMP/MMP14; of note the addition of a receptor agonist (SEW 2871) was not able to up-regulate MMPs thus suggesting that S1P1 signalling plays a trophic role in MSCs. In parallel experiments, the expression of MMP2 and MT1-MMP/MMP14 was evaluated in MSCs cultured in low oxygen conditions (2%) in order to mimic the hypoxic microenvironment occurring in a damaged/regenerating tissue. These preliminary data contribute to add new insights into the functional mechanisms by which MSCs exert beneficial effects on tissue repair/regeneration.File | Dimensione | Formato | |
---|---|---|---|
regulation.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Creative commons
Dimensione
417.78 kB
Formato
Adobe PDF
|
417.78 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.